• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种-感染模式影响并使针对奥密克戎亚变体的T细胞分化和中和反应多样化。

SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants.

作者信息

Wang Junxiang, Li Kaiyi, Mei Xinyue, Cao Jinpeng, Zhong Jiaying, Huang Peiyu, Luo Qi, Li Guichang, Wei Rui, Zhong Nanshan, Zhao Zhuxiang, Wang Zhongfang

机构信息

State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong, China.

Guangzhou Laboratory, Bioland, Guangzhou, Guangdong, China.

出版信息

Cell Discov. 2022 Dec 21;8(1):136. doi: 10.1038/s41421-022-00501-3.

DOI:10.1038/s41421-022-00501-3
PMID:36543767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9769462/
Abstract

The effects of different SARS-CoV-2 vaccinations and variant infection histories on imprinting population immunity and their influence on emerging escape mutants remain unclear. We found that Omicron (BA.1) breakthrough infection, regardless of vaccination with two-dose mRNA vaccines (M-M-o) or two-dose inactivated vaccines (I-I-o), led to higher neutralizing antibody levels against different variants and stronger T-cell responses than Delta breakthrough infection after two-dose inactivated vaccine vaccination (I-I-δ). Furthermore, different vaccination-infection patterns imprinted virus-specific T-cell differentiation; M-M-ο showed higher S/M/N/E-specific CD4 T cells and less portion of virus-specific CD45RACD27CD8 T cells by ex vivo assay. Breakthrough infection groups showed higher proliferation and multi-function capacity by in vitro assay than three-dose inactivated vaccine inoculated group (I-I-I). Thus, under wide vaccination coverage, the higher immunogenicity with the Omicron variant may have helped to eliminate the population of Delta variant. Overall, our data contribute to our understanding of immune imprinting in different sub-populations and may guide future vaccination programs.

摘要

不同的新冠病毒疫苗接种情况和变异株感染史对群体免疫印记的影响及其对新出现的逃逸突变株的影响尚不清楚。我们发现,奥密克戎(BA.1)突破性感染,无论接种两剂mRNA疫苗(M-M-o)还是两剂灭活疫苗(I-I-o),与接种两剂灭活疫苗后出现的德尔塔突破性感染(I-I-δ)相比,都会导致针对不同变异株的中和抗体水平更高,T细胞反应更强。此外,不同的疫苗接种-感染模式会影响病毒特异性T细胞分化;通过体外实验检测,M-M-ο显示出更高的S/M/N/E特异性CD4 T细胞,以及病毒特异性CD45RACD27CD8 T细胞的比例更低。通过体外实验检测,突破性感染组比接种三剂灭活疫苗的组(I-I-I)表现出更高的增殖和多功能能力。因此,在广泛的疫苗接种覆盖下,奥密克戎变异株更高的免疫原性可能有助于清除德尔塔变异株群体。总体而言,我们的数据有助于我们了解不同亚群体中的免疫印记,并可能为未来的疫苗接种计划提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/436cfd870b06/41421_2022_501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/3517d14be8f9/41421_2022_501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/cccd68d8482d/41421_2022_501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/f9e4cefb063b/41421_2022_501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/43654351a3fa/41421_2022_501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/436cfd870b06/41421_2022_501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/3517d14be8f9/41421_2022_501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/cccd68d8482d/41421_2022_501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/f9e4cefb063b/41421_2022_501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/43654351a3fa/41421_2022_501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/9772319/436cfd870b06/41421_2022_501_Fig5_HTML.jpg

相似文献

1
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种-感染模式影响并使针对奥密克戎亚变体的T细胞分化和中和反应多样化。
Cell Discov. 2022 Dec 21;8(1):136. doi: 10.1038/s41421-022-00501-3.
2
Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.在中国,两剂科兴新冠疫苗后接种一剂mRNA和三种平台型新冠疫苗作为第三剂的免疫原性、持久性和安全性:一项随机、双盲、安慰剂对照的2期试验。
EClinicalMedicine. 2022 Sep 28;54:101680. doi: 10.1016/j.eclinm.2022.101680. eCollection 2022 Dec.
3
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination.第三剂 mRNA 疫苗接种后对 SARS-CoV-2 奥密克戎 BA.1、BA.2 和 BA.3 的抗体亲和力和跨变体中和作用。
Nat Commun. 2022 Aug 8;13(1):4617. doi: 10.1038/s41467-022-32298-w.
4
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.
5
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.Omicron BA.1 变异株突破感染同源第三剂 Comirnaty® COVID-19 疫苗后的养老院居民:寻找保护相关因素。
J Med Virol. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. Epub 2022 May 25.
6
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine.在先前接种科兴疫苗的老年人中,接种ChAdOx-1或BNT162b2加强针后针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的中和抗体及T细胞反应
Immun Ageing. 2022 May 24;19(1):24. doi: 10.1186/s12979-022-00279-8.
7
Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron.接种疫苗后的德尔塔变异株感染可引发针对严重急性呼吸综合征冠状病毒 2 型奥密克戎的强烈中和免疫。
J Infect Dis. 2022 Nov 1;226(9):1551-1555. doi: 10.1093/infdis/jiac149.
8
mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines.mRNA加强疫苗接种可增强在接受mRNA疫苗或灭活病毒疫苗初免的个体中针对新冠病毒奥密克戎变异株的抗体反应。
Vaccines (Basel). 2022 Jun 30;10(7):1057. doi: 10.3390/vaccines10071057.
9
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.评估 2 至 3 剂 BNT162b2 mRNA COVID-19 疫苗后针对 SARS-CoV-2 变异株的中和抗体反应。
JAMA Netw Open. 2022 May 2;5(5):e2210780. doi: 10.1001/jamanetworkopen.2022.10780.
10
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.科兴新冠疫苗第三针诱导广泛而有效的适应性免疫应答,能识别 SARS-CoV-2 德尔塔和奥密克戎变异株。
Emerg Microbes Infect. 2022 Dec;11(1):1524-1536. doi: 10.1080/22221751.2022.2081614.

引用本文的文献

1
Emerging landscape of lncRNA-miRNA interactions as architects of gene expression patterns.作为基因表达模式构建者的lncRNA-miRNA相互作用的新态势。
Mol Biol Rep. 2025 Aug 8;52(1):810. doi: 10.1007/s11033-025-10906-4.
2
Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history.具有不同疫苗接种史的小鼠中,单价和多价亚单位疫苗针对新冠病毒变异株的免疫原性。
Microbiol Spectr. 2025 Jul 17:e0290724. doi: 10.1128/spectrum.02907-24.
3
Age associated SARS-CoV-2 immune responses provide insights into population immunity over four years since the COVID-19 pandemic.

本文引用的文献

1
Immune boosting by B.1.1.529 Omicron) depends on previous SARS-CoV-2 exposure.免疫增强作用取决于先前的 SARS-CoV-2 暴露情况。
Science. 2022 Jul 15;377(6603):eabq1841. doi: 10.1126/science.abq1841.
2
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.突破性感染后回忆性免疫的程度和时间由 SARS-CoV-2 变体决定。
Immunity. 2022 Jul 12;55(7):1316-1326.e4. doi: 10.1016/j.immuni.2022.05.018. Epub 2022 May 27.
3
Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials.
自新冠疫情爆发四年以来,与年龄相关的新冠病毒免疫反应为了解群体免疫提供了见解。
Sci Rep. 2025 Jul 2;15(1):23183. doi: 10.1038/s41598-025-05737-z.
4
Delayed Viral Clearance Accompanied by Early Impaired Humoral and Virus-Specific T-Cell Response in Patients with Coronavirus Disease 2019 and Interstitial Lung Disease.2019冠状病毒病合并间质性肺疾病患者病毒清除延迟,伴有早期体液免疫和病毒特异性T细胞反应受损
Vaccines (Basel). 2025 Jun 19;13(6):655. doi: 10.3390/vaccines13060655.
5
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2.奥密克戎BA.5.2在患者中的自然感染可引发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的广泛免疫反应。
Microorganisms. 2025 Mar 26;13(4):746. doi: 10.3390/microorganisms13040746.
6
Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection.奥密克戎BA.2.2突破性感染和奥密克戎BA.5再次感染后的体液免疫和细胞免疫反应。
iScience. 2024 Jun 15;27(7):110283. doi: 10.1016/j.isci.2024.110283. eCollection 2024 Jul 19.
7
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.新冠疫情期间和之后对 SARS-CoV-2 发病机制的新认识。
Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.
8
Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection.初始 COVID-19 严重程度受 SARS-CoV-2 特异性 T 细胞印记影响,T 细胞记忆并反作用于再感染。
Signal Transduct Target Ther. 2024 May 29;9(1):141. doi: 10.1038/s41392-024-01867-4.
9
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire.SARS-CoV-2 突破感染增强了 T 细胞反应的幅度、广度和表位库。
Cell Rep Med. 2024 Jun 18;5(6):101583. doi: 10.1016/j.xcrm.2024.101583. Epub 2024 May 22.
10
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.用鞭毛蛋白对三RBD支架蛋白进行鼻腔接种可引发针对包括JN.1在内的SARS-CoV-2变体的长期保护。
Signal Transduct Target Ther. 2024 Apr 27;9(1):114. doi: 10.1038/s41392-024-01822-3.
两中心、单盲、随机对照 2 期临床试验中 CoronaVac 加强针的 6 个月随访结果。
Nat Commun. 2022 Jun 3;13(1):3100. doi: 10.1038/s41467-022-30864-w.
4
Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022.理解 2022 年初香港第五波 COVID-19 中快速抗原检测对 SARS-CoV-2 传播的影响。
Emerg Microbes Infect. 2022 Dec;11(1):1394-1401. doi: 10.1080/22221751.2022.2076616.
5
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.中和 SARS-CoV-2 奥密克戎亚谱系 BA.1、BA.1.1 和 BA.2.
Cell Host Microbe. 2022 Aug 10;30(8):1093-1102.e3. doi: 10.1016/j.chom.2022.04.014. Epub 2022 Apr 25.
6
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.第三次接种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)mRNA疫苗后对奥密克戎反应性B细胞记忆的有效回忆
Cell. 2022 May 26;185(11):1875-1887.e8. doi: 10.1016/j.cell.2022.04.009. Epub 2022 Apr 8.
7
SARS-CoV-2-specific CD4 T cells are associated with long-term persistence of neutralizing antibodies.SARS-CoV-2 特异性 CD4 T 细胞与中和抗体的长期持久性相关。
Signal Transduct Target Ther. 2022 Apr 23;7(1):132. doi: 10.1038/s41392-022-00978-0.
8
Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron.评估新型严重急性呼吸综合征冠状病毒2变种的传播性:从德尔塔到奥密克戎
Vaccines (Basel). 2022 Mar 24;10(4):496. doi: 10.3390/vaccines10040496.
9
COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.2022 年 1 月 6 日至 2022 年 3 月 21 日,中国香港特别行政区的 COVID-19 死亡率和疫苗接种率。
MMWR Morb Mortal Wkly Rep. 2022 Apr 15;71(15):545-548. doi: 10.15585/mmwr.mm7115e1.
10
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.印记的新冠病毒特异性记忆淋巴细胞定义了混合免疫。
Cell. 2022 Apr 28;185(9):1588-1601.e14. doi: 10.1016/j.cell.2022.03.018. Epub 2022 Mar 17.